A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma
- PMID: 11591806
- DOI: 10.4049/jimmunol.167.8.4747
A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma
Abstract
The homing of hemopoietic stem cells to the bone marrow is mediated by specific interactions occurring between CXCR4, which is expressed on hemopoietic stem cells, and its ligand, stromal cell-derived factor-1 (SDF-1), a CXC chemokine secreted by bone marrow stromal cells. In the present study we evaluated the possibility that neuroblastoma cells use a mechanism similar to that used by hemopoietic stem cells to home to the bone marrow and adhere to bone marrow stromal cells. Our study suggests that CXCR4 expression may be a general characteristic of neuroblastoma cells. SH-SY5Y neuroblastoma cells express not only CXCR4, but also its ligand, SDF-1. CXCR4 expression on SH-SY5Y neuroblastoma cells is tightly regulated by tumor cell-derived SDF-1, as demonstrated by the ability of neutralizing Abs against human SDF-1alpha to up-regulate CXCR4 expression on the tumor cells. The reduction in CXCR4 expression following short term exposure to recombinant human SDF-1alpha can be recovered as a result of de novo receptor synthesis. Recombinant human SDF-1alpha induces the migration of CXCR4-expressing SH-SY5Y neuroblastoma cells in CXCR4- and heterotrimeric G protein-dependent manners. Furthermore, SH-SY5Y cells interact at multiple levels with bone marrow components, as evidenced by the fact that bone marrow-derived constituents promote SH-SY5Y cell migration, adhesion to bone marrow stromal cells, and proliferation. These results suggest that SH-SY5Y neuroblastoma cells are equipped with adequate machinery to support their homing to the bone marrow. Therefore, the ability of neuroblastoma tumors to preferentially form metastases in the bone marrow may be influenced by a set of complex CXCR4-SDF-1 interactions.
Similar articles
-
Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation.Cancer Res. 2005 Nov 1;65(21):9891-8. doi: 10.1158/0008-5472.CAN-05-1293. Cancer Res. 2005. PMID: 16267013
-
Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy.Cancer Res. 2003 Nov 15;63(22):7926-35. Cancer Res. 2003. PMID: 14633723
-
The chemokine receptor CXCR4 enhances integrin-mediated in vitro adhesion and facilitates engraftment of leukemic precursor-B cells in the bone marrow.Exp Hematol. 2001 Dec;29(12):1439-47. doi: 10.1016/s0301-472x(01)00741-x. Exp Hematol. 2001. PMID: 11750103
-
Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice.Exp Hematol. 2006 Aug;34(8):967-75. doi: 10.1016/j.exphem.2006.04.002. Exp Hematol. 2006. PMID: 16863903 Review.
-
Mechanism of human stem cell migration and repopulation of NOD/SCID and B2mnull NOD/SCID mice. The role of SDF-1/CXCR4 interactions.Ann N Y Acad Sci. 2001 Jun;938:83-95. doi: 10.1111/j.1749-6632.2001.tb03577.x. Ann N Y Acad Sci. 2001. PMID: 11458529 Review.
Cited by
-
ABCG2 is a potential marker of tumor-initiating cells in breast cancer.Tumour Biol. 2015 Dec;36(12):9233-43. doi: 10.1007/s13277-015-3647-0. Epub 2015 Jun 20. Tumour Biol. 2015. PMID: 26091795
-
Bone marrow mesenchymal stem cells increase motility of prostate cancer cells via production of stromal cell-derived factor-1α.J Cell Mol Med. 2013 Feb;17(2):287-92. doi: 10.1111/jcmm.12010. Epub 2013 Jan 10. J Cell Mol Med. 2013. PMID: 23301946 Free PMC article.
-
Tissue microenvironment modulates CXCR4 expression and tumor metastasis in neuroblastoma.Neoplasia. 2007 Jan;9(1):36-46. doi: 10.1593/neo.06670. Neoplasia. 2007. PMID: 17325742 Free PMC article.
-
Development of a tumor-selective approach to treat metastatic cancer.PLoS One. 2006 Dec 20;1(1):e23. doi: 10.1371/journal.pone.0000023. PLoS One. 2006. PMID: 17183650 Free PMC article.
-
Exploratory studies on development of the chemokine receptor CXCR4 antagonists toward downsizing.Perspect Medicin Chem. 2008 Feb 10;2:1-9. doi: 10.4137/pmc.s422. Perspect Medicin Chem. 2008. PMID: 19787093 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical